Surgical group(n=35) (%) Medical group(n=35) (%)
Male 29(82.86%) 27(77.14%)
Female 6(17.14%) 8(22.86%)
Diabetes 35(100%) 35(100%)
Central SBO 10(28.57%) 9(25.71%)
No growth in culture 11(31.43%) 9(25.71%)
Pseudomonas 10(28.57%) 14(40%)
Fungal 10(28.57%) 5(14.29%)
Mixed flora 2(5.71%) 5(14.29%)
Klebsiella 1(2.86%) 2(5.71%)
Bacteroids 1(2.86%) 0(0%)
Antimicrobials given Antimicrobials given Antimicrobials given
Voriconazole 18(51.43%) 16(45.71%)
Piperacillin 17(48.57%) 19(54.29%)
Ciprofloxacin 12(34.29%) 11(31.43%)
Ceftazidime 9(25.71%) 7(20%)
Cefaperazone 8(22.86%) 7(20%)
Linezolid 4(11.43%) 1(2.86%)
Meropenem 4(11.43%) 2(5.71%)
Vancomycin 3(8.57%) 1(2.86%)
Minocycline 5(14.29%) 2(5.71%)
Fluconazole 4(11.43%) 0(0%)
Levofloxacin 2(5.71%) 2(5.71%)
Clindamycin 1(2.86%) 0(0%)